Zenas BioPharma, Inc. (ZBIO) compared with its closest peers (CLYM, CGEM, KYTX, PGEN, CBIO). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Climb Bio and Cullinan Therapeutics: names this company as a competitor in its 10-K.
| Company | Market Cap | P/E |
|---|---|---|
| Climb Bio, Inc. (CLYM) | $817.03M | — |
| Cullinan Therapeutics, Inc. (CGEM) | $1.32B | — |
| Kyverna Therapeutics, Inc. (KYTX) | $448.98M | — |
| Precigen, Inc. (PGEN) | $2.45B | — |
| Crescent Biopharma, Inc. (CBIO) | $717.99M | — |
| X4 Pharmaceuticals, Inc. (XFOR) | $330.12M | — |
| Janux Therapeutics, Inc. (JANX) | $1.04B | — |
| Contineum Therapeutics, Inc. (CTNM) | $554.52M | — |
| Relay Therapeutics, Inc. (RLAY) | $4.13B | — |
| Vor Biopharma Inc. (VOR) | $1.21B | 1.9 |
| Sector P/E (Healthcare) | 19.4 |
| Industry P/E (Pharmaceutical Products) | 15.1 |
ZBIO overview · ZBIO earnings · ZBIO financials · ZBIO KPIs · ZBIO documents · ZBIO ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.